Bioxytran (BIXT) Revenue (2010 - 2018)
Bioxytran (BIXT) posted Revenue of $20,310 for Q2 2018, down 48.5% from $39,472 a year earlier but up 52.5% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Revenue (2010 - 2018) Analysis & Trends
For the trailing twelve months through Jun 30, 2018, Revenue at Bioxytran was $177,795, down 13.8% year-over-year; for FY2017, it was $191,077, down 22.5% from FY2016.
- Annual Revenue has declined for four consecutive years, with a five-year compound annual growth rate of -9.4% (FY2012 to FY2017).
- In prior years, Bioxytran's Revenue was $246,495 in FY2016 (-3.6%), $255,822 in FY2015 (-7.2%), $275,616 in FY2014 (-34.0%) and $417,336 in FY2013 (+33.4%).
- Quarterly Revenue has run from a low of -$2.07 million in Q4 2015 to a high of $208,356 in Q1 2014 over five years.
- On a year-over-year basis, Revenue increased in two of the last seven quarters, with an average decline of 16.8%.
- The strongest year-over-year quarter for Revenue in the past five years was Q3 2013, with growth of 461.1%; the weakest was Q1 2017, with a decline of 76.4%.
- According to Business Quant data, Revenue for the three prior quarters was $13,316 (Q1 2018), $32,190 (Q4 2017) and $111,979 (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 20,310.00 |
| Mar 31, 2018 | 13,316.00 |
| Dec 31, 2017 | 32,190.00 |
| Sep 30, 2017 | 111,979.00 |
| Jun 30, 2017 | 39,472.00 |
| Mar 31, 2017 | 7,436.00 |
| Dec 31, 2016 | 58,200.00 |
| Sep 30, 2016 | 101,140.00 |
| Jun 30, 2016 | 55,630.00 |
| Mar 31, 2016 | 31,525.00 |
| Dec 31, 2015 | -2.07 Mn |
| Sep 30, 2015 | 110,780.00 |
| Jun 30, 2015 | 59,400.00 |
| Mar 31, 2015 | 62,490.00 |
| Dec 31, 2014 | -12,082.00 |
| Sep 30, 2014 | 41,498.00 |
| Jun 30, 2014 | 37,844.00 |
| Mar 31, 2014 | 208,356.00 |
| Dec 31, 2013 | 148,449.00 |
| Sep 30, 2013 | 55,693.00 |
API Access
Bioxytran Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();